EVOLUTION OF MYCOBACTERIUM TUBERCULOSIS AND IMPLICATIONS FOR VACCINE DEVELOPMENT

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Tuberculosis (TB) presents a significant global health challenge, exacerbated by multidrug resistance.
• Current TB vaccines show limited efficacy, and recent vaccine candidates have failed in clinical trials.
• Understanding host-pathogen interactions is crucial for developing effective TB vaccines.

Purpose of the Study:

• To explore novel concepts for TB vaccine design.
• To identify potential new vaccine antigens beyond conserved T cell epitopes.
• To investigate the role of co-evolution between Mycobacterium tuberculosis complex (MTBC) and human genetic diversity in vaccine development.

Main Methods:

• Analysis of T cell antigens within the MTBC.
• Identification of conserved versus variable T cell epitopes.
• Investigation of co-evolutionary dynamics between bacterial and human genetic diversity.

Main Results:

• Most MTBC T cell antigens are conserved and under purifying selection, suggesting limited protective immunity.
• A subset of highly variable T cell epitopes has been identified as potential alternative vaccine targets.
• Evidence suggests long-term co-evolution between human-adapted MTBC and human hosts.

Conclusions:

• Novel TB vaccine strategies are urgently required.
• Highly variable T cell epitopes represent promising candidates for next-generation TB vaccines.
• Leveraging insights from host-pathogen genetic co-evolution can uncover new TB vaccine targets.